Income Statement (TTM)
DANAMECO Medical Joint Stock Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 12-31 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 778,826 | 701,364 | 644,623 | 478,611 | 448,837 | 546,755 | 620,695 | 599,858 | 473,794 | 333,974 | 239,554 | 216,452 | 196,825 |
| Change (%) | -9.95 | -8.09 | -25.75 | -6.22 | 21.82 | 13.52 | -3.36 | -21.02 | -29.51 | -28.27 | -9.64 | -9.07 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 633,504 | 564,270 | 513,397 | 375,155 | 376,279 | 438,561 | 496,381 | 480,589 | 427,963 | 329,011 | 274,420 | 212,934 | 163,474 |
| Change (%) | -10.93 | -9.02 | -26.93 | 0.30 | 16.55 | 13.18 | -3.18 | -10.95 | -23.12 | -16.59 | -22.41 | -23.23 | |
| % of Revenue | 81.34 | 80.45 | 79.64 | 78.38 | 83.83 | 80.21 | 79.97 | 80.12 | 90.33 | 98.51 | 114.55 | 98.38 | 83.06 |
| Gross Operating Profit | 145,321 | 137,095 | 131,226 | 103,456 | 72,558 | 108,195 | 124,314 | 119,269 | 45,831 | 4,963 | -34,866 | 3,517 | 33,351 |
| Change (%) | -5.66 | -4.28 | -21.16 | -29.87 | 49.11 | 14.90 | -4.06 | -61.57 | -89.17 | -802.51 | -110.09 | 848.22 | |
| % of Revenue | 18.66 | 19.55 | 20.36 | 21.62 | 16.17 | 19.79 | 20.03 | 19.88 | 9.67 | 1.49 | -14.55 | 1.62 | 16.94 |
| SG&A | 89,939 | 83,574 | 79,159 | 72,671 | 38,278 | 48,365 | 51,610 | 48,124 | 46,633 | 38,119 | 34,606 | 31,285 | 11,533 |
| Change (%) | -7.08 | -5.28 | -8.20 | -47.33 | 26.35 | 6.71 | -6.75 | -3.10 | -18.26 | -9.22 | -9.60 | -63.14 | |
| % of Revenue | 11.55 | 11.92 | 12.28 | 15.18 | 8.53 | 8.85 | 8.31 | 8.02 | 9.84 | 11.41 | 14.45 | 14.45 | 5.86 |
| R&D | |||||||||||||
| Change (%) | |||||||||||||
| % of Revenue | |||||||||||||
| OpEx | 723,444 | 647,844 | 592,555 | 447,826 | 414,557 | 486,926 | 547,991 | 528,713 | 474,596 | 367,130 | 309,026 | 244,219 | 175,007 |
| Change (%) | -10.45 | -8.53 | -24.42 | -7.43 | 17.46 | 12.54 | -3.52 | -10.24 | -22.64 | -15.83 | -20.97 | -28.34 | |
| % of Revenue | 92.89 | 92.37 | 91.92 | 93.57 | 92.36 | 89.06 | 88.29 | 88.14 | 100.17 | 109.93 | 129.00 | 112.83 | 88.92 |
| Operating Income | 55,382 | 53,520 | 52,068 | 30,785 | 34,280 | 59,829 | 72,704 | 71,145 | -801 | -33,156 | -69,472 | -27,768 | 21,818 |
| Change (%) | -3.36 | -2.71 | -40.87 | 11.35 | 74.53 | 21.52 | -2.14 | -101.13 | 4,036.99 | 109.53 | -60.03 | -178.57 | |
| % of Revenue | 7.11 | 7.63 | 8.08 | 6.43 | 7.64 | 10.94 | 11.71 | 11.86 | -0.17 | -9.93 | -29.00 | -12.83 | 11.08 |
| Interest Expense | -9,225 | -15,245 | -18,321 | -19,221 | -20,483 | -23,521 | -22,955 | -23,075 | -23,639 | -16,982 | -16,679 | -12,014 | -7,933 |
| Change (%) | 65.27 | 20.18 | 4.91 | 6.57 | 14.83 | -2.41 | 0.52 | 2.45 | -28.16 | -1.79 | -27.97 | -33.96 | |
| % of Revenue | -1.18 | -2.17 | -2.84 | -4.02 | -4.56 | -4.30 | -3.70 | -3.85 | -4.99 | -5.08 | -6.96 | -5.55 | -4.03 |
| Net Income | 37,052 | 31,178 | 27,586 | 9,824 | 12,055 | 30,102 | 40,750 | 38,986 | -25,427 | -39,638 | -78,685 | -55,361 | -262 |
| Change (%) | -15.85 | -11.52 | -64.39 | 22.71 | 149.71 | 35.37 | -4.33 | -165.22 | 55.89 | 98.51 | -29.64 | -99.53 | |
| % of Revenue | 4.76 | 4.45 | 4.28 | 2.05 | 2.69 | 5.51 | 6.57 | 6.50 | -5.37 | -11.87 | -32.85 | -25.58 | -0.13 |
Source: Capital IQ
